An announcement from Arbutus Biopharma Corporation (ABUS) is now available.
Dr. Michael Sofia will retire as Chief Scientific Officer from Arbutus Biopharma Corporation at the end of 2024, with the company publicly announcing his departure the day after his notification. This change could signal a new direction for the company and is of interest to investors monitoring executive movements within the biopharmaceutical industry.
Learn more about ABUS stock on TipRanks’ Stock Analysis page.